Source:http://linkedlifedata.com/resource/pubmed/id/19837659
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
49
|
pubmed:dateCreated |
2009-11-30
|
pubmed:abstractText |
Both vascular endothelial growth factor receptors (VEGFR) and integrins are major regulators of VEGF-induced angiogenesis. Previous work has shown that beta3 integrin can regulate negatively VEGFR2 expression. Here we show that beta3 integrin can regulate negatively VEGF-mediated angiogenesis by limiting the interaction of the co-receptor NRP1 (neuropilin-1) with VEGFR2. In the presence of alphav beta3 integrin, NRP1 contributed minimally to VEGF-induced angiogenic processes in vivo, ex vivo, and in vitro. Conversely, when beta3 integrin expression is absent or low or its function is blocked with RGD-mimetic inhibitors, VEGF-mediated responses became NRP1-dependent. Indeed, combined inhibition of beta3 integrin and NRP1 decreased VEGF-mediated angiogenic responses further than individual inhibition of these receptors. We also show that alphav beta3 integrin can associate with NRP1 in a VEGF-dependent fashion. Our data suggest that beta3 integrin may, in part, negatively regulate VEGF signaling by sequestering NRP1 and preventing it from interacting with VEGFR2.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Integrin alphaVbeta3,
http://linkedlifedata.com/resource/pubmed/chemical/Neuropilin-1,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1083-351X
|
pubmed:author |
pubmed-author:BakerMarianneM,
pubmed-author:Hodivala-DilkeKairbaan MKM,
pubmed-author:KostourouVassilikiV,
pubmed-author:MarshallJohn FJF,
pubmed-author:ReynoldsAndrew RAR,
pubmed-author:ReynoldsLouise ELE,
pubmed-author:RobinsonStephen DSD,
pubmed-author:TavoraBernardoB,
pubmed-author:da SilvaRita GraçaRG
|
pubmed:issnType |
Electronic
|
pubmed:day |
4
|
pubmed:volume |
284
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
33966-81
|
pubmed:dateRevised |
2011-3-3
|
pubmed:meshHeading |
pubmed-meshheading:19837659-Animals,
pubmed-meshheading:19837659-Aorta,
pubmed-meshheading:19837659-Base Sequence,
pubmed-meshheading:19837659-Endothelial Cells,
pubmed-meshheading:19837659-Humans,
pubmed-meshheading:19837659-Integrin alphaVbeta3,
pubmed-meshheading:19837659-Mice,
pubmed-meshheading:19837659-Microcirculation,
pubmed-meshheading:19837659-Molecular Sequence Data,
pubmed-meshheading:19837659-Neovascularization, Pathologic,
pubmed-meshheading:19837659-Neuropilin-1,
pubmed-meshheading:19837659-Signal Transduction,
pubmed-meshheading:19837659-Vascular Endothelial Growth Factor A,
pubmed-meshheading:19837659-Vascular Endothelial Growth Factor Receptor-2,
pubmed-meshheading:19837659-Wound Healing
|
pubmed:year |
2009
|
pubmed:articleTitle |
Alphav beta3 integrin limits the contribution of neuropilin-1 to vascular endothelial growth factor-induced angiogenesis.
|
pubmed:affiliation |
Adhesion and Angiogenesis Laboratory, Tumour Biology Centre, Institute of Cancer, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, United Kingdom.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|